Disease‐specific quality of life · people requiring intervention for short saphenous vein varices
2 findings from 1 review
Complications at 1 year · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Recanalisation or persistence of reflux at 6 weeks · people requiring intervention for short saphenous vein varices
Ultrasound‐guided foam sclerotherapy showed no clear difference in recanalisation or persistence of reflux at 6 weeks compared with conventional surgery (low certainty).
1 finding from 1 review
Recurrence of reflux at 1 year · people requiring intervention for short saphenous vein varices
Ultrasound‐guided foam sclerotherapy showed no clear difference in recurrence of reflux at 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Technical success · people with GSV incompetence
Ultrasound‐guided foam sclerotherapy (UGFS) may leads to lower technical success (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
2 findings from 1 review
Recurrence · people with GSV incompetence
Ultrasound‐guided foam sclerotherapy (UGFS) showed no clear difference in recurrence (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
Ultrasound‐guided foam sclerotherapy (UGFS) showed no clear difference in long‐term recurrence (≥ 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
1 finding from 1 review
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
QoL · people with GSV incompetence
1 finding from 1 review
Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins
1 finding from 1 review
Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins
Foam showed no clear difference in adverse events ‐ hyperpigmentation ( compared with sclerotherapy (any sclerosant) (low certainty).
1 finding from 1 review
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Foam may leads to higher adverse events ‐ matting ( compared with sclerotherapy (any sclerosant) (low certainty).
1 finding from 1 review
Pain ( · people with telangiectasias and reticular veins
1 finding from 1 review
Recurrence · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term recurrence (> 5 years) · people with GSV incompetence
It is very uncertain whether endovenous laser ablation (EVLA) changes long‐term recurrence (> 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).
1 finding from 1 review
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
QoL · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Technical success · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in technical success (< 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (low certainty).
2 findings from 1 review